Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.

@article{Egred2005UnderuseOB,
  title={Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.},
  author={Mohaned Egred and Susan Shaw and Bader A Mohammad and Peter I. Waitt and Erwin Rodrigues},
  journal={QJM : monthly journal of the Association of Physicians},
  year={2005},
  volume={98 7},
  pages={493-7}
}
BACKGROUND Beta-blockers (BB) improve morbidity and mortality in ischaemic heart disease. There is a general reluctance to use BB, especially in patients with chronic obstructive pulmonary disease (COPD), which is perceived as an absolute contraindication. As large numbers of patients are labelled with COPD without objective evidence, they may miss out on the benefit from these drugs. AIM To assess the use of BB in patients with COPD admitted with acute coronary syndrome (ACS), and to assess… CONTINUE READING